Showing results (321-330 of 840) with videos related to
Sort By:
Pageof 84
Journal of Lipid Research|July 6, 2010
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapyStephen J Nicholls, W H Wilson Tang, Heather Scoffone, et al.Congestive Heart Failure (Greenwich, Conn.)|January 3, 2013
Prognostic implications of relative hypochromia in ambulatory patients with chronic systolic heart failureCesar Simbaqueba, Kevin Shrestha, Maria Patarroyo, et al.Respiratory Research|January 24, 2013
Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertensionSamar Farha, Daniel Laskowski, Deepa George, et al.Free Radical Biology & Medicine|May 15, 2012
Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolismMarissa Martinez, Adam Cuker, Angela Mills, et al.Clinical Chemistry|November 20, 2016
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes MellitusW H Wilson Tang, Zeneng Wang, Xinmin S Li, et al.Journal of the American Heart Association|July 30, 2016
Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident Myocardial Infarction in Patients Undergoing Elective Cardiac EvaluationJaana Hartiala, Carrie V Breton, W H Wilson Tang, et al.The American Journal of Cardiology|September 5, 2006
Plasma myeloperoxidase levels in patients with chronic heart failureW H Wilson Tang, Marie-Luise Brennan, Kiran Philip, et al.Journal of the American College of Cardiology|July 6, 2004
Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic linkRonald M Witteles, W H Wilson Tang, Aamer H Jamali, et al.Arthritis Research & Therapy|June 10, 2018
Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritisUnnikrishnan M Chandrasekharan, Zeneng Wang, Yuping Wu, et al.Journal of Cardiovascular Electrophysiology|December 11, 2013
A clinical prediction rule to identify patients at heightened risk for early demise following cardiac resynchronization therapyJohn Rickard, Alan Cheng, David Spragg, et al.Pageof 84